A potential biomarker for age-related macular degeneration disease: iris freckles.
Age-related macular degeneration
Iris freckles
Ultraviole exposure
Journal
International journal of retina and vitreous
ISSN: 2056-9920
Titre abrégé: Int J Retina Vitreous
Pays: England
ID NLM: 101677897
Informations de publication
Date de publication:
05 Sep 2024
05 Sep 2024
Historique:
received:
20
06
2024
accepted:
15
08
2024
medline:
6
9
2024
pubmed:
6
9
2024
entrez:
5
9
2024
Statut:
epublish
Résumé
To determine the potential relationship between age-related macular degeneration and iris freckles. In this case-control study, iris photographs of 300 eyes of 300 patients diagnosed with age-related macular degeneration and 300 eyes of 300 healthy volunteers were obtained with the help of a high-resolution mobile phone camera. The evaluated iris photographs were classified according to the Descriptive Iris Color Classification Scale. The average age of the AMD group is 73.05 ± 6.93, and the average age of the control group is 73.43 ± 5.72. (p = 0.124) While freckles were present in 200 (66.7%) of the patients in the AMD group, freckles were not observed in 100 patients (33.3%) of AMD group. While freckles were present in 142 (47.3%) of the patients in the control group, freckles were not observed in 158 of control group(52.7%). There was a significant difference in the presence of freckles between the two groups. (p < 0.001) The average number of freckles in the AMD group was 3.97 ± 3.07, and the number of freckles in the control group was 3.06 ± 2.55. (p = 0.001) CONCLUSION: We think that evaluation of iris details, especially the presence of iris freckles, should be used routinely in age-related macular degeneration screening. The risk of age-related macular degeneration can be predicted by evaluating iris details, which is an easy and inexpensive method.
Identifiants
pubmed: 39238056
doi: 10.1186/s40942-024-00575-z
pii: 10.1186/s40942-024-00575-z
doi:
Types de publication
Journal Article
Langues
eng
Pagination
62Informations de copyright
© 2024. The Author(s).
Références
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728–38.
doi: 10.1016/S0140-6736(12)60282-7
pubmed: 22559899
Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102(11):1640–2.
doi: 10.1001/archopht.1984.01040031330019
pubmed: 6208888
Schick T, Ersoy L, Lechanteur YT, Saksens NT, Hoyng CB, den Hollander AI, Kirchhof B, Fauser S. History of sunlight exposure is a risk factor for age-related macular degeneration. Retina. 2016;36:787–90.
doi: 10.1097/IAE.0000000000000756
pubmed: 26441265
Sui GY, Liu GC, Liu GY, Gao YY, Deng Y, Wang WY, Tong SH, Wang L. Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis. Br J Ophthalmol. 2013;97(4):389–94.
doi: 10.1136/bjophthalmol-2012-302281
pubmed: 23143904
Qu Y, Jiang Y, Zhang G, Luo H, Hu W, Wu Z, Meng X, Chen R, Jia H, Sun X. Association of exposure to ultraviolet radiation and warm-season ozone air pollution with incident age-related macular degeneration: a nationwide cohort study in China. Sci Total Environ. 2024;938:173580. Epub 2024 May 27. PMID: 38810762.
doi: 10.1016/j.scitotenv.2024.173580
pubmed: 38810762
Eagle RC. Iris pigmentation and pigmented lesions: an ultrastructural study. Trans Am Ophthalmol Soc. 1988;86:581–687.
pubmed: 2979031
pmcid: 1298824
Shields JA, Shields CL. Intraocular tumors: an Atlas andTextbook. Philadelphia: Wolters Kluwer; 2008.
Shields CL, Kancherla S, Patel J, Vijayvargiya P, Suriano MM, Kolbus E, Badami A, Sharma P, Jacobs E, Voluck M, Zhang Z, Kansal R, Shields PW, Bianciotto CG, Shields JA. Clinical survey of 3680 iris tumors based on patient age at presentation. Ophthalmology. 2012;119(2):407–14.
doi: 10.1016/j.ophtha.2011.07.059
pubmed: 22035581
Grigore M, Furtunescu F, Minca D, Costache M, Garbe C, Simionescu O. The iris signal: blue periphery, tan collaret and freckles pattern strong indicators for epidermal skin cancer in South-Eastern Europe. J Eur Acad Dermatol Venereol. 2018;32(10):1662–7.
doi: 10.1111/jdv.14929
pubmed: 29524265
Schwab C, Mayer C, Zalaudek I, Riedl R, Richtig M, Wackernagel W, Hofmann-Wellenhof R, Richtig G, Langmann G, Tarmann L, Wedrich A, Richtig E. Iris Freckles a potential biomarker for chronic Sun damage. Invest Ophthalmol Vis Sci. 2017;58(6):BIO174–9.
doi: 10.1167/iovs.17-21751
pubmed: 28715582
Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR. Beckman Initiative for Macular Research Classification Committee. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844–51.
doi: 10.1016/j.ophtha.2012.10.036
pubmed: 23332590
Age-related macular degeneration. Diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2018. Jan. (NICE Guideline, No. 82.).
Simionescu O, Grigore M, Furtunescu F, Minca D, Chitu V, Costache M. A novel iris colour classification scale. Ann Res Rev Biol. 2014;4:2525–34.
doi: 10.9734/ARRB/2014/9906
Cui R, Widlund HR, Feige E, Lin JY, Wilensky DL, Igras VE, D’Orazio J, Fung CY, Schanbacher CF, Granter SR, Fisher DE. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 2007;128(5):853–64.
doi: 10.1016/j.cell.2006.12.045
pubmed: 17350573
LüofflerG,PetridesPE.BiochemieUndPathobiochemie. Berlin: Springer; 2013.
Rabe JH, Mamelak AJ, McElgunn PJ, Morison WL, Sauder DN. Photoaging: mechanisms and repair. J Am Acad Dermatol. 2006;55:1–19.
doi: 10.1016/j.jaad.2005.05.010
pubmed: 16781287
Sample A, He YY. Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed. 2018;34(1):13–24.
doi: 10.1111/phpp.12329
pubmed: 28703311